Bacterial microbiome of lungs in COPD

• Published in: International journal of chronic obstructive pulmonary disease Vol. 9; no. default; pp. 229 - 238
• Main Authors: Sin, Don, Sze, Marc, Hogg, James
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2014; Dove Medical Press Ltd; Dove Medical Press
• Subjects: Analysis; Anti-Bacterial Agents - therapeutic use; Bacteria; Bacterial infections; Chronic obstructive pulmonary disease; Disease Progression; Gastrointestinal Tract - microbiology; Health aspects; Humans; Hypotheses; Infections; Lung - drug effects; Lung - immunology; Lung - microbiology; Lung - physiopathology; Lung diseases, Obstructive; Lungs; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Neutrophils; Pathogenesis; Pulmonary Disease, Chronic Obstructive - drug therapy; Pulmonary Disease, Chronic Obstructive - epidemiology; Pulmonary Disease, Chronic Obstructive - immunology; Pulmonary Disease, Chronic Obstructive - microbiology; Pulmonary Disease, Chronic Obstructive - physiopathology; Review; Risk Factors; Skin; Smoking - adverse effects; Smoking - epidemiology; lungs; bacterial microbiome; chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death in the world. Although smoking is the main risk factor for this disease, only a minority of smokers develop COPD. Why this happens is largely unknown. Recent discoveries by the human microbiome project have sh...